Loading clinical trials...
Loading clinical trials...
Phase IV Double-Blind Randomized Study to Evaluate Safety and Efficacy of Interferon Beta-1a (Avonex) Plus Simvastatin (Zocor) Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Over a One Year Period
Conditions
Interventions
Avonex/Zocor
Locations
1
United States
University of North Carolina-Chapel Hill MS clinic within the Neuroscience Hospital
Chapel Hill, North Carolina, United States
Start Date
September 1, 2004
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2007
Last Updated
March 5, 2008
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
University of North Carolina
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions